Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus

Psychosomatic Medicine

Volumn 65, Issue 3, 2003, Pages 427-434

  Pereira, Deidre Byrnes ^a,b,c   Antoni, Michael H ^a,b   Danielson, Aimee ^a   Simon, Trudi ^b   Efantis Potter, JoNell ^b   Carver, Charles S ^a   Durán, Ron E F ^a   Ironson, Gail ^a,b   Klimas, Nancy ^a,b   O'Sullivan, Mary Jo ^b  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

HIV; Human papillomavirus (HPV); Psychoneuroimmunology (PNI); Squamous intraepithelial lesions (SIL); Stress; Women

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSURVEILLANCE; LOGISTIC REGRESSION ANALYSIS; PAPANICOLAOU TEST; PRIORITY JOURNAL; STRESS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

AFRICAN AMERICANS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE PROGRESSION; FEMALE; FLORIDA; FOCUS GROUPS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC SURVEILLANCE; LIFE CHANGE EVENTS; LYMPHOCYTE SUBSETS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; PSYCHONEUROIMMUNOLOGY; RISK FACTORS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; WEST INDIES;

EID: 12444269114     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PSY.0000041620.37866.89     Document Type: Article

References (50)

1. Hankins C, Coutlee F, Lapointe N, Simard P, Tran T, Samson J, Hum L. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ 1999;160:185-91.
2. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999;21:33-41.
3. Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R, Clarke L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 1999;180:824-36.
4. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-36.
5. Rezza G, Giuliani M, Branca M, Benedetto A, Migliore G, Garbuglia AR, D'Ubaldo C, Pezzotti P, Cappiello G, Pomponi Formiconi D, Suligoi B, Schiesari A, Ippolito G, Giacomini G. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1 induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol 1997;13:937-43.
6. Stratton P, Gupta P, Riester K, Fox H, Zorrilla C, Tuomala R, Eriksen N, Vajaranant M, Minkoff H, Fowler MG. Cervical dysplasia on cervicovaginal Papanicolaou smear among HIV-1-infected pregnant and nonpregnant women. Women and Infants Transmission Study. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:300-7.
7. Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:170-4.
8. Cuthill S, Maiman M, Fruchter RG, Lopatinsky, Cheng CC. Complications after treatment of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. J Reprod Med 1995;40:823-8.
9. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997;89:76-80.
10. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1999;11:1-44.
11. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. SEER Cancer Statistics Review, 1973-1997. Bethesda (MD): National Cancer Institute; 2000.
12. Antoni MH, Goodkin K. Cervical neoplasia, human papillomavirus and psychoneuroimmunology. In: Friedman H, Klein TW, Friedman AL, editors. Psychoneuroimmunology, stress, and infection. Boca Raton: CRC Press; 1996. p. 243-62.
13. Glaser R, Kiecolt-Glaser JK. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998;105:35S-42S.
14. Glaser R, Friedman SB, Smyth J, Ader R, Bijur P, Brunell P, Cohen N, Krilov LR, Lifrak ST, Stone A, Toffler P. The differential impact of training stress and final examination stress on herpes virus latency at the United States military academy at West Point. Brain Behav Immun 1999;13:240-51.
15. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry 1997;54:279-85.
16. Kimerling R, Calhoun KS, Forehand R, Armistead L, Morse E, Morse P, Clark R, Clark I. Traumatic stress in HIV-infected women. AIDS Educ Prev 1999;11:321-30.
17. Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, Cai J, Folds JD, Evans DL. Progression to AIDS. The effects of stress, depressive symptoms, and social support. Psychosom Med 1999;61:397-406.
18. Kemeny ME, Dean L. Effects of AIDS-related bereavement on HIV progression among New York City gay men. AIDS Educ Prev 1995;7:36-47.
19. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 285:1466-74.
20. Goodkin K, Antoni MH, Blaney PH. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J Psychosom Res 1986;30:67-76.
21. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
22. Sarason IG, Johnson JH, Siegel JM. Assessing, the impact of life change: development of the Life Experiences Survey. J Consult Clin Psychol 1978;46:932-46.
23. Antoni MH, Goodkin K. Host moderator variables in the promotion of cervical neoplasia. II. Dimensions of life stress. J Psychosom Res 1989;33:457-67.
24. Ironson G, Wynings C, Schneiderman N, Baum A, Rodriguez M, Greenwood D, Benight C, Antoni M, LaPerriere A, Huang HS, Klimas N, Fletcher MA. Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med 1997;59:128-41.
25. Wright VC, Lickrish GM. Basic and advanced colposcopy: a practical handbook for diagnosis and treatment. Houston: Biomedical Communications, Inc.; 1989.
26. Byrnes D, Antoni MH, Goodkin K, Ironson G, Asthana D, Efantis-Potter J, Simon T, Munajj J, Fletcher M. Stressful events, pessimism, and natural killer cell cytotoxicity in HIV+ Black women at risk for cervical cancer. Psychosom Med 1998;60:714-22.
27. Cerqueira EM, Santoro CL, Donozo NF, Freitas BA, Pereira CA, Bevilacqua RG, Machado-Santelli GM. Genetic damage in exfo liated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol 1998;42:639-49.
28. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998;12:1459-64.
29. Ahdieh L. Pregnancy and human immunodeficiency virus. Clin Obstet Gynecol 2001;44:154-66.
30. Abbas A, Lichtman A, Pober J. Cellular and molecular immunology. Philadelphia: Saunders; 1991.
31. Heard I, Bergeron C, Jeannel D, Henrion R, Kazatchkine MD. Papanicolaou smears in human immunodeficiency virusseropositive women during follow-up. Obstet Gynecol 1995;86:749-53.
32. Gullotta G, Margariti PA, Rabitti C, Balsamo G, Valle D, Capelli A, Mancuso S. Cytology, histology, and colposcopy in the diagnosis of neoplastic non-invasive epithelial lesions of the cervix. Eur J Gynaecol Oncol 1997;18:36-8.
33. Mayeaux EJ Jr, Harper MB, Abreo F, Pope JB, Phillips GS. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology. J Fam Pract 1995;40:57-62.
34. Ickovics JR, Druley JA, Morrill AC, Grigorenko E, Rodin J. "A grief observed": the experience of HIV-related illness and death among women in a clinic-based sample in New Haven, Connecticut. J Consult Clin Psychol 1998;66:958-66.
35. Kemeny ME, Dean L. Effects of AIDS-related bereavement on HIV progression among New York City gay men. AIDS Educ Prev 1995;7:36-47.
36. Goodkin K, Feaster DJ, Tuttle R, Blaney NT, Kumar M, Baum MK, Shapshak P, Fletcher MA. Bereavement in associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men. Clin Diagn Lab Immunol 1996;3:109-18.
37. Goodkin K, Feaster DJ, Asthana D, Blaney NT, Kumar M, Baldewicz T, Ruttle RS, Maher KJ, Baum MK, Shapshak P, Fletcher MA. A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits. Clin Diagn Lab Immunol 1998;5:382-91.
38. Goodkin K, Blaney NT, Feaster DJ, Baldewicz T, Burkhalter JE, Leeds B. A randomized controlled clinical trial of a bereavement support group intervention in human immunodeficiency virus type 1-seropositive and -seronegative homosexual men. Arch Gen Psychiatry 1999;56:52-9.
39. Goodkin K, Baldewicz TT, Asthana D, Khamis I, Blaney NT, Kumar M, Burkhalter JE, Leeds B, Shapshak P. A bereavement support group intervention affects plasma burden of human immunodeficiency virus type 1. Report of a randomized controlled trial. J Hum Virol 2001;4:44-54.
40. Antoni MH, Goodkin K. Host moderator variables in the promotion of cervical neoplasia. I. Personality facets. J Psychosom Res 1988;32:327-38.
41. Meier CA. Mechanisms of immunosuppression by glucocorticoids. Eur J Endocrinol 1996;134:50.
42. Olaitan A, Johnson MA, Reid WM, Poulter LW. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin Exp Immunol 1998;112:100-4.
43. Demas P, Schoenbaum EE, Wills TA, Doll L, Klein RS. Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev 1995;7:429-42.
44. Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991;165:658-62.
45. Mehta S, Moore RD, Graham NMH. Potential factors affecting adherence with HIV therapy. AIDS 1997;11:1665-70.
46. Schneiderman N, Antoni MH, Ironson G. Cognitive behavioral stress management and secondary prevention in HIV/AIDS. Psych AIDS Exch 1997;22:1-8.
47. West-Edwards CAC, Byrnes-Pereira D, Greenwood DU. Tailoring a psychosocial intervention for HIV+ African-American women. Invited address at the 105th Convention of the American Psychological Association; August 1997; Chicago (IL).
48. Lutgendorf SK, Antoni MH, Ironson G, Klimas N, Kumar M, Starr K, McCabe P, Cleven K, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus type 2 antibody titers in symptomatic HIV-seropositive gay men. J Consult Clin Psychol 1997;65:31-43.
49. Antoni MH, Cruess S, Cruess DG, Kumar M, Lutgendorf S, Ironson G, Dettmer E, Williams J, Klimas N, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med 2000;22:1-11.
50. Antoni MH, Cruess DG, Cruess S, Lutgendorf S, Kumar M, Ironson G, Klimas N, Fletcher MA, Schneiderman N. Cognitivebehavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol 2000;68:31-45